KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Vitality Peptide Labs: 13 Kovera certificates.
The lab's record shows 13 certificates printed for Vitality Peptide Labs, analysed between 2 Apr 2026 and 2 Apr 2026, covering 13 products. Median HPLC purity is 99.93%. Kovera graded 13 as a pass and 0 as a fail.
13
certificates
99.93%
median purity
13
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 13 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 9 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
13 AS PRINTEDBPC-157 · 1BPC-157/TB-500 · 1CJC-1295 (No DAC)/Ipamorelin · 1CJC-1295 DAC · 1GHK-Cu · 1Glow · 1Ipamorelin · 1Klow · 1Retatrutide · 1Sermorelin · 1TB-500 (Thymosin B4) · 1Tesamorelin · 1Tirzepatide · 1
Every certificate
NEWEST FIRST · 13 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-FBCBED | BPC-157 | VPL-BPC-033026-01 | 99.946% | 112.6%11.26 of 10 mg | 2 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-CE5F8C | Retatrutide | VPL-RETA-033026-01 | 99.934% | 106.6%31.98 of 30 mg | 2 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B40597 | TB-500 (Thymosin B4) | VPL-TB500-033026-01 | 99.942% | 107.6%10.76 of 10 mg | 2 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-A671F1 | Klow | VPL-KLOW-033026-01 | 99.842% | 114.6%91.67 of 80 mg | 2 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-9FF1F2 | Tesamorelin | VPL-TESA-033026-01 | 99.926% | 111.1%11.11 of 10 mg | 2 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8740F6 | Glow | VPL-GLOW-033026-01 | 99.824% | 108.0%75.62 of 70 mg | 2 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-80ABB4 | BPC-157/TB-500 | VPL-BPC-TB-033026-01 | 99.954% | 112.1%22.42 of 20 mg | 2 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-6C8696 | CJC-1295 DAC | VPL-CJC-DAC-033026-01 | 99.922% | 112.6%5.63 of 5 mg | 2 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-581FB8 | Tirzepatide | VPL-TIRZ-033026-01 | 99.966% | 115.9%34.78 of 30 mg | 2 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-3E9DE1 | Ipamorelin | VPL-IPA-033026-01 | 99.929% | 116.3%11.63 of 10 mg | 2 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-135378 | CJC-1295 (No DAC)/Ipamorelin | VPL-CJC-IPA-033026-01 | 99.916% | 110.8%11.08 of 10 mg | 2 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-06C98C | GHK-Cu | VPL-GHKCU-033026-01 | 99.983% | 112.4%56.18 of 50 mg | 2 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-00BD2C | Sermorelin | VPL-SERM-033026-01 | 99.976% | 106.1%10.61 of 10 mg | 2 Apr 2026 | PASS | Kovera ↗our verifier → |